Description

This grant supports early-stage clinical trials and research projects focused on developing and testing innovative, multidisciplinary interventions for neurodegenerative diseases. The aim is to improve therapeutic effectiveness and patient quality of life through novel approaches that combine pharmacological and non-pharmacological strategies, leverage digital technologies (including AI and wearables), and promote broad stakeholder engagement. Projects are expected to generate robust evidence on safety and efficacy, investigate new mechanisms of action, and utilize or integrate existing data infrastructures. The program encourages collaboration, data sharing, and the involvement of social sciences and humanities to maximize societal impact and facilitate the adoption of new therapies.